Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52. 1997

Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
Institut National de la Santé et de la Recherche Médicale Unité 33, 94276 Le Kremlin-Bicêtre Cédex, France. L50951@sakura.dudpc.kyoto-u.ac.jp

FKBP52 (HSP56, p59, HBI) is the 59-kDa immunosuppressant FK506-binding protein and has peptidyl prolyl isomerase as well as a chaperone-like activity in vitro. FKBP52 associates with the heat shock protein HSP90 and is included in the steroid hormone receptor complexes in vivo. FKBP52 possesses a well conserved phosphorylation site for casein kinase II (CK2) that was previously shown to be associated with HSP90. Here we examined whether FKBP52 is phosphorylated by CK2 both in vivo and in vitro. Recombinant rabbit FKBP52 was phosphorylated by purified CK2. We expressed and purified deletion mutants of FKBP52 to determine the site(s) phosphorylated by CK2. Thr-143 in the hinge I region was identified as the major phosphorylation site for CK2. A synthetic peptide corresponding to this region was phosphorylated by CK2, and the peptide competitively inhibited the phosphorylation of other substrates by CK2. The [32P]phosphate labeling of FKBP52-expressing cells revealed that the same site is also phosphorylated in vivo. FK506 binding to FKBP52 did not affect the phosphorylation by CK2 and, conversely, the FK506-binding activity of FKBP52 was not affected by the phosphorylation. Most importantly, CK2-phosphorylated FKBP52 did not bind to HSP90. These results indicate that CK2 phosphorylates FKBP52 both in vitro and in vivo and thus may regulate the protein composition of chaperone-containing complexes such as those of steroid receptors and certain protein kinases.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002352 Carrier Proteins Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. Binding Proteins,Carrier Protein,Transport Protein,Transport Proteins,Binding Protein,Protein, Carrier,Proteins, Carrier
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006360 Heat-Shock Proteins Proteins which are synthesized in eukaryotic organisms and bacteria in response to hyperthermia and other environmental stresses. They increase thermal tolerance and perform functions essential to cell survival under these conditions. Stress Protein,Stress Proteins,Heat-Shock Protein,Heat Shock Protein,Heat Shock Proteins,Protein, Stress
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
August 2011, Current opinion in pharmacology,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
May 2002, The Journal of biological chemistry,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
March 1999, Insect biochemistry and molecular biology,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
October 1991, Journal of biochemistry,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
December 1997, Biochemical and biophysical research communications,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
February 1993, Journal of cell science,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
April 1992, The Biochemical journal,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
November 1997, Genes & development,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
January 1992, Ciba Foundation symposium,
Y Miyata, and B Chambraud, and C Radanyi, and J Leclerc, and M C Lebeau, and J M Renoir, and R Shirai, and M G Catelli, and I Yahara, and E E Baulieu
June 2003, Genomics,
Copied contents to your clipboard!